Free Account Opening + AMC Free Demat
Loading...

G R Infraprojects IPO vs Glenmark Life Sciences IPO

Comparision between G R Infraprojects IPO and Glenmark Life Sciences IPO.

IPO Details

G R Infraprojects IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Glenmark Life Sciences IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of G R Infraprojects IPO is up to ₹963.28 Cr whereas the issue size of the Glenmark Life Sciences IPO is up to ₹1,513.60 Cr. The final issue price of G R Infraprojects IPO is ₹837.00 per share and of Glenmark Life Sciences IPO is ₹720.00 per share.

  G R Infraprojects IPO Glenmark Life Sciences IPO
Face Value ₹5 per share ₹2 per share
Issue Price (Lower) ₹828.00 per share ₹695.00 per share
Issue Price (Upper) ₹837.00 per share ₹720.00 per share
Issue Price (Final) ₹837.00 per share ₹720.00 per share
Discount (Retail)
Discount (Employee) ₹42.00 per share
Market Lot Size 17 shares 20 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,060.00 Cr
OFS Issue Size 1,15,08,704 shares 63,00,000 shares
OFS Issue Size (Amount) up to ₹963.28 Cr up to ₹453.60 Cr
Issue Size Total 1,15,08,704 shares
Issue Size Total (Amount) up to ₹963.28 Cr up to ₹1,513.60 Cr

IPO Timetable

G R Infraprojects IPO opens on Jul 07, 2021, while Glenmark Life Sciences IPO opens on Jul 27, 2021. The closing date of G R Infraprojects IPO and Glenmark Life Sciences IPO is Jul 09, 2021, and Jul 29, 2021, respectively.

  G R Infraprojects IPO Glenmark Life Sciences IPO
Anchor Bid Date
Issue Open Jul 07, 2021 Jul 27, 2021
Issue Close Jul 09, 2021 Jul 29, 2021
Basis Of Allotment (Tentative) Jul 14, 2021 Aug 03, 2021
Initiation of Refunds (Tentative) Jul 15, 2021 Aug 04, 2021
Credit of Share (Tentative) Jul 16, 2021 Aug 05, 2021
Listing date (Tentative) Jul 19, 2021 Aug 06, 2021
Anchor Lockin End date 1 Aug 13, 2021 Sep 02, 2021
Anchor Lockin End date 2 Oct 12, 2021 Nov 01, 2021

Financials

G R Infraprojects IPO P/E ratio is , as compared to Glenmark Life Sciences IPO P/E ratio of .

  G R Infraprojects IPO Glenmark Life Sciences IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 1,01,160.45 77,834.16 58,287.31
Total Revenue 79,069.43 64,237.05 53,255.30
Profit After Tax 9,532.21 8,008.32 7,166.38
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total Revenue 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92
Promoter Shareholding (Pre-Issue) 88.04% 100%
Promoter Shareholding (Post-Issue) 86.54% 82.84%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the G R Infraprojects IPO retail investors (RII) are offered 39,49,297 shares while in Glenmark Life Sciences IPO retail investors are offered 39,49,297 shares. Qualified institutional buyers (QIB) are offered 56,41,851 shares in G R Infraprojects IPO and 42,42,379 shares in Glenmark Life Sciences IPO.

  G R Infraprojects IPO Glenmark Life Sciences IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 56,41,851 shares 42,42,379 shares
NII 16,92,556 shares 32,32,770 shares
RII 39,49,297 shares 75,43,130 shares
Employee 2,25,000 shares 0 shares
Others
Total 1,15,08,704 shares 1,50,18,279 shares

Bids Received (Subscription)

G R Infraprojects IPO subscribed 102.58x in total, whereas Glenmark Life Sciences IPO subscribed 44.17x.

  G R Infraprojects IPO Glenmark Life Sciences IPO
QIB (times) 168.58x 36.97x
NII (times) 238.04x 122.54x
Big NII (times)
Small NII (times)
RII (times) 12.57x 14.63x
Employee (times) 1.37x
Other (times)
Total (times) 102.58x 44.17x

Comments

Add a public comment...